Zileuton

齐留通

Report date: 2025/10/27 20:00:53
NME

Base Information

Drug NameZileuton
Drug Alias NameZileuton CR其留通Zileutonum齐留酮ZYFLO CR +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionArachidonate 5-lipoxygenase inhibitors
TargetsArachidonate 5-lipoxygenase
Therapy Area/IndicationsAcne VulgarisIdiopathic Pulmonary FibrosisPulmonary Disease, Chronic Obstructive +[6] 
Global Approved IndicationsAsthma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1996/12/09
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of MinnesotaChiesi Usa IncBarbara Ann Karmanos Cancer Institute +[5] 
Active IndicationsN/A
Inactive IndicationsAcne VulgarisIdiopathic Pulmonary FibrosisPulmonary Disease, Chronic Obstructive +[6] 

Other Information

ATC CodeR
Related LinksWikipediaDrugBankKEGG